José Antonio García Erce: Honored For Publishing in SANGRE Magazine
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared on LinkedIn:
”Honored for publishing in SANGRE Magazine
Editorial on patient blood management: challenge and opportunity for hematologists
On the eve of the National Congress of the Spanish Society of Hematology and Hemotherapy (SEHH) I have been accepted as an Editorial for the SANGRE Magazine.
The editorial team has given me the invaluable opportunity to address all Hematology and Hemotherapy professionals to defend the situation of privilege and responsibility, for our preparation and vision, -clinical, diagnostic, therapy and management-, in the implementation and development of the Patient Blood Management Programs.
I invite the coordination, cooperation and integration of the different working groups (Erythropathology) and societies (Thrombosis and Haemostasis – Transfusion – PBM) to lead the promotion, protection and prevention of Blood Health in accordance with the recommendations of the OMS.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies